BRPI0910534A2 - terapia antiviral - Google Patents

terapia antiviral

Info

Publication number
BRPI0910534A2
BRPI0910534A2 BRPI0910534A BRPI0910534A BRPI0910534A2 BR PI0910534 A2 BRPI0910534 A2 BR PI0910534A2 BR PI0910534 A BRPI0910534 A BR PI0910534A BR PI0910534 A BRPI0910534 A BR PI0910534A BR PI0910534 A2 BRPI0910534 A2 BR PI0910534A2
Authority
BR
Brazil
Prior art keywords
antiviral therapy
antiviral
therapy
Prior art date
Application number
BRPI0910534A
Other languages
English (en)
Inventor
Edward Oakeley
François H T Duong
Magdalena Sarasin-Filipowicz
Markus Heim
Witold Filipowicz
Original Assignee
Novartis Forschungsstiftung
Univ Hospital Basel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Forschungsstiftung, Univ Hospital Basel filed Critical Novartis Forschungsstiftung
Publication of BRPI0910534A2 publication Critical patent/BRPI0910534A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0910534A 2008-04-21 2009-04-20 terapia antiviral BRPI0910534A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154878 2008-04-21
PCT/EP2009/054641 WO2009130176A1 (en) 2008-04-21 2009-04-20 Antiviral Therapy

Publications (1)

Publication Number Publication Date
BRPI0910534A2 true BRPI0910534A2 (pt) 2015-09-29

Family

ID=39830378

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910534A BRPI0910534A2 (pt) 2008-04-21 2009-04-20 terapia antiviral

Country Status (16)

Country Link
US (1) US20110117563A1 (pt)
EP (1) EP2271776A1 (pt)
JP (1) JP2011519551A (pt)
KR (1) KR20110014979A (pt)
CN (1) CN102016072A (pt)
AU (1) AU2009240021B2 (pt)
BR (1) BRPI0910534A2 (pt)
CA (1) CA2719078A1 (pt)
IL (1) IL208351A0 (pt)
MA (1) MA32274B1 (pt)
MX (1) MX2010011587A (pt)
NZ (1) NZ588144A (pt)
RU (1) RU2010146701A (pt)
SG (1) SG190570A1 (pt)
WO (1) WO2009130176A1 (pt)
ZA (1) ZA201006647B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120251546A1 (en) * 2009-09-03 2012-10-04 Medimmune Llc Type 1 inteferon diagnostic
AU2010317996A1 (en) * 2009-11-14 2012-05-10 F. Hoffmann-La Roche Ag Biomarkers for predicting rapid response to HCV treatment
CN106442984B (zh) 2010-04-21 2020-03-13 米密德诊断学有限公司 区分细菌与病毒感染的标记物和决定因素以及其使用方法
CA2863819C (en) 2012-02-09 2021-11-23 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
CN103740755A (zh) * 2013-12-23 2014-04-23 中国农业大学 猪ifit1基因在抗prrs病毒中的应用
CN111624346A (zh) 2014-08-14 2020-09-04 米密德诊断学有限公司 用于预测及/或决定预后的套组
US20170234873A1 (en) 2014-10-14 2017-08-17 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
CA2968650A1 (en) 2014-12-11 2016-06-16 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
US11466331B2 (en) 2016-03-03 2022-10-11 Memed Diagnostics Ltd. RNA determinants for distinguishing between bacterial and viral infections
WO2017149547A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
CA3027341A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
WO2018011796A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
EP3519833B1 (en) 2016-09-29 2024-08-14 MeMed Diagnostics Ltd. Methods of prognosis and treatment
EP3519834A4 (en) 2016-09-29 2020-06-17 MeMed Diagnostics Ltd. RISK ASSESSMENT AND DISEASE CLASSIFICATION METHODS
US10209260B2 (en) 2017-07-05 2019-02-19 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20080161203A1 (en) * 2006-12-27 2008-07-03 Su Chun-Lin Markers identified for liver fibrosis and cirrhosis and the microarray panel thereof

Also Published As

Publication number Publication date
CN102016072A (zh) 2011-04-13
RU2010146701A (ru) 2012-05-27
KR20110014979A (ko) 2011-02-14
MA32274B1 (fr) 2011-05-02
JP2011519551A (ja) 2011-07-14
AU2009240021B2 (en) 2013-01-10
NZ588144A (en) 2012-04-27
WO2009130176A1 (en) 2009-10-29
SG190570A1 (en) 2013-06-28
EP2271776A1 (en) 2011-01-12
IL208351A0 (en) 2010-12-30
US20110117563A1 (en) 2011-05-19
MX2010011587A (es) 2011-05-03
AU2009240021A1 (en) 2009-10-29
ZA201006647B (en) 2011-05-25
CA2719078A1 (en) 2009-10-29
WO2009130176A9 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
LTC2932970I2 (lt) Antivirusinė terapija
BRPI0910534A2 (pt) terapia antiviral
SMT201600351B (it) Composti antivirali
PL2280973T3 (pl) Analogi karba-nukleozydowe do leczenia przeciwwirusowego
BRPI0916931A2 (pt) agentes terapêuticos
EP2296593A4 (en) MEDICAL HEAD COVER
IL207826A0 (en) Antiviral therapeutic agents
BRPI0907376A2 (pt) Fotobiorretador
BRPI0906366A2 (pt) Inalador
BRPI0914817A2 (pt) inalador
BRPI0906779A2 (pt) Inalador
BRPI0907522A2 (pt) biarlamidas
LT3150178T (lt) Stimuliavimo aparatas
BRPI0920743A2 (pt) ribonucleases terapeuticas
BRPI0906367A2 (pt) inalador
BRPI0820410A2 (pt) Lactans substituídos terapêuticos
BRPI0818598A2 (pt) agentes terapêuticos - 802
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
HRP20160577T1 (hr) Liječenje osteoartritisa
AT507449A3 (de) Dämmstoffbefestiger
BRPI0906369A2 (pt) Inalador
EP2138172A4 (en) ANTIVIRAL ACTIVE SUBSTANCE
PL2090199T3 (pl) Tułów
EP2309854A4 (en) ACCELERATED THERAPY:
BRPI0909764A2 (pt) compostos terapêuticos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.